King George Hospital is a Government General Hospital located in Visakhapatnam, Andhra Pradesh, India. It is the largest and busiest government hospital in Andhra Pradesh. The hospital served the needs of north coastal Andhra Pradesh and adjacent Orissa for more than 150 years.

There are 1,237 beds in King George Hospital.

During the past decade, King George Hospital conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 17 clinical trials were completed, i.e. on average, 68% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 14 clinical trials were completed. i.e. 127.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "King George Hospital" #1 sponsor was "Allergan" with 4 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Bharat Biotech International Limited" with 2 trials sponsored and "MacroGenics" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "King George Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Incozen Therapeutics Pvt Ltd" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "King George Hospital" are "COVID-19" (4 trials), "Gastroparesis" (4 trials), "Atopic Dermatitis" (3 trials), "Diabetes Mellitus" (3 trials) and "Lupus Erythematosus, Systemic" (2 trials). Many other conditions were trialed in "King George Hospital" in a lesser frequency.

Most popular intervention types in "King George Hospital" are "Drug" (32 trials), "Biological" (6 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Relamorelin" (3 trials), "Baricitinib" (2 trials), "13-valent Pneumococcal conjugate vaccine" (1 trials) and "ASLAN004" (1 trials). Other intervention names were less common.

The vast majority of trials in "King George Hospital" are 32 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "King George Hospital". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in King George Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in King George Hospital, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".